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Background: Tanzania is among the countries in the world where the cervical cancer incidence is estimated to
be highest. Acknowledging an increase in the burden of cervical cancer, VIA was implemented as a regional
cervical cancer screening strategy in Tanzania in 2002. With the aim of describing risk factors for VIA positivity
and determinants of screening attendances in Tanzania, this paper present the results from a comparative
analysis performed among women who are reached and not reached by the screening program”.
Methods: 14 107 women aged 25–59 enrolled in a cervical cancer screening program in Dar es Salaam in the
period 2002 – 2008. The women underwent VIA examination and took part in a structured questionnaire interview.
Socioeconomic characteristics, sexual behavior, HIV status and high-risk (HR) HPV infection were determined in a
subpopulation of 890 who participated and 845 who did not participate in the screening.
Results: Being widowed/separated OR=1.41 (95% CI: 1.17-1.66), of high parity OR=3.19 (95% CI: 1.84-5.48) of low
education OR= 4.30 (95% CI: 3.50-5.31) and married at a young age OR=2.17 (95% CI: 1.37-3.07) were associated
with being VIA positive. Women who participated in the screening were more likely to be HIV positive OR= 1.59
(95% CI. 1.14-2.25) in comparison with women who had never attended screening, while no difference was found
in the prevalence of HR-HPV infection among women who had attended screening and women who had not
attended screening.
Conclusion: Women who are widowed/separated, of high parity, of low education and married at a young age
are more likely to be VIA positive and thus at risk of developing cervical cancer. The study further documents that a
referral linkage between the HIV care and treatment program and the cervical cancer screening program is in place
in the setting studied, where HIV positive were more likely to participate in the cervical cancer screening program
than HIV negative women.
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With an estimated 530,000 new cases annually, cervical
cancer is the third most common cancer in women and
has to be considered a major health concern worldwide
[1]. More than 85% of the global burden of cervical can-
cer occurs in developing countries. The high-risk regions
are Eastern and Western Africa. In these regions the* Correspondence: vrasch@health.sdu.dk
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reproduction in any medium, provided the orage standardized incidence rate is greater than 30 per
100,000. In comparison, the age standardized incidence
rate in North America and Australia/New Zealand is less
than 8 per 100,000. Cervical cancer is responsible for
275,000 deaths annually, about 88% of which occurs
in developing countries [1]. One of the explanations
behind the high mortality in developing countries is the
lack of effective screening programs for cervical cancer.
As a consequence, no clinically significant reduction in
the incidences of cervical cancer has occurred [2,3].
In contrast, there has been a major decline in cervical
cancer mortality in developed countries after the intro-
duction of population-based screening programs basedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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abnormalities [4].
A screening program based on Pap smears requires
several steps, including health care providers who are
able to collect the cells from the cervix and prepare
slides, cytopathologists who can stain and read the slides
and a communication network that can convey the
results to the women and arrange for a second visit if
the smear is abnormal. The infrastructure required for
these steps is unavailable in most developing countries.
Therefore there is a need for more simple screening
methods which can be interpreted immediately and
combined with treatment. Visual inspection of the cervix
after acetic acid application (VIA) is believed to be
an effective method for screening in resource-limited
settings [5]. VIA is performed by a trained health care
provider who applies acetic acid solution to the cervix
and then observes the transformation zone of the cervix
for 1 to 2 minutes for acetowhite epithelium, which is
thought to be indicative of abnormal cellular changes
[6]. The implementation of VIA as a screening strategy
has shown promising results and screening programs
based on this methodology are being implemented
increasingly in low income countries [7,8].
Tanzania is, with an age-standardized incidence rate of
50.9 cases per 100,000 women, and an age-standardized
mortality rate of 37.5 per 100,000 women due to cervical
cancer, one of the countries in the world hardest hit by
the disease. The high burden of disease is plausible due
to high prevalence of HPV and HIV. Women who are
HIV-positive are more likely to develop cervical cancer
than HIV-negative women [9]. With an HIV prevalence
rate of 9% among women aged 15–49, this has sig-
nificant implications for the cervical cancer screening
program [10].
Acknowledging an increase in the burden of cervical
cancer, VIA was implemented as a regional cervical
cancer screening strategy in 2002. The initiative was
supported by the World Health Organization (WHO)
and the International Agency for Research on Cancer
(IARC). These organizations assisted Ocean Road Cancer
Institute (ORCI), the national cancer hospital in Tanzania,
in implementing a national cervical cancer screening
program, based on VIA, for the detection of precan-
cerous lesions. The program targeted women aged 25–
59 years and initially used acetic acid and Lugol’s iodine
to evaluate the comparative accuracy of the tests [7]. The
initial project ended in 2005 and cervical cancer screen-
ing services have since then been routinely available in
a few satellite sites, including Dar es Salaam, Kigoma,
Kilimanjaro and Morogoro. Since 2005, efforts have been
made to scale up the service to regional and district
hospitals through training of health providers and by
integrating the service in the reproductive and childhealth clinics and/or gynecologic clinics. The service is
offered free of charge and is done by trained doctors and
nurses. With the aim of describing risk factors for VIA
positivity and determinants of screening attendances in
Dar es Salaam, Tanzania, this paper present the results from
a comparative analysis performed among women who
are reached and not reached by the screening program.
Methods
Study population and enrollment
The present study enrolled a subgroup of women aged
25–59 years, who had participated in the National
Cervical Cancer Screening program at ORCI between
November 2002 and December 2008. In this period,
15,439 women were screened for cervical cancer. In all,
1246 women aged either below 25 or above 59 years and
86 women with incomplete forms were excluded from
the study, leaving 14,107 women. Of these, 932 women
were diagnosed as having a positive VIA test and the
remaining 13,175 as having a negative VIA test.
To evaluate whether women reached by the screening
program differed from those not screened, all women
who participated in the screening program from Febru-
ary to June 2008 were compared with a reference group
of women who had never participated in the screening
program. The reference group was recruited from three
municipalities of Dar es Salaam. To identify a represen-
tative group of women who had never attended a
screening, a random sample of 1500 houses was selected
from the national house hold survey [11] using multi-
stage cluster sampling where three wards from each of
the three municipalities in Dar es Salaam were randomly
selected and from each ward five streets were randomly
selected to ensure equal representation from the three
districts. The recruitment was done between February
and June 2008 by a research assistant who worked
as a social worker. The community leaders, who were
responsible for the sampled streets, assisted in the
recruitment of the women who were informed about the
project via home visits and through megaphone cam-
paigns. Health information was provided through the
campaigns and the women were invited to attend out-
reach screening for cervical cancer at the nearest muni-
cipal hospital. In all, 1599 women were found to be
eligible for the study and a total of 845 women aged
25–59 were enrolled. All women who were enrolled in
the study were interviewed by the principal investigator
and a trained research assistant.
Data collection
VIA status and socioeconomic and reproductive
characteristics
All women participating in the screening program were
screened by means of VIA, which was performed by a
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to 1) Easier preparation of acetic acid versus Lugol’s
iodine and; 2) Higher specificity of VIA compared to
VILI which reduces the risk of false positive results.
In addition, information on socioeconomic and repro-
ductive characteristics was collected using a structured
questionnaire. Since the screening staff at ORCI had
been trained in VIA and were experienced in using VIA
to detect precancerous lesions, this test was used rather
than the colposcopic examination.
Cervical cancer risk factors and screening attendance
The 890 women from the sub population of women par-
ticipating in the screening program and the reference
group of 845 non-screened women were interviewed
about their sexual behavior, general health condition,
STIs, and circumcision of male partners.
Cervical samples were collected and placed in a trans-
port medium and kept frozen at −18°C. The samples
were kept at ORCI for a maximum of two months
and then stored on dry ice and shipped to Germany
(Tuebingen University) and tested for HR-HPV by
means of the Hybrid Capture 2 (HC2 Qiagen, Hilden,
Germany) high-risk (HR) probe.
VIA was performed according to WHO/IARC proto-
col. Acetic acid was applied to the cervix using a cotton
swab and the cervix was visualized after a minute with
the aid of a halogen light source. The test was classified
positive if acetowhite epithelium appeared near the
Squamous Columnar Junction. The test was classified
suspicious for cancer if a cauliflower-like fungating mass
or ulcer was noted on the cervix. If the cervical lining
was smooth, uniform, with no acetowhite lesion the test
was classified as negative [12].
After the gynaecological examination, the women were
offered voluntary counseling and testing for HIV. HIV
status was determined using the National algorithm for
HIV testing [13]. The serological test was based on the
Trinity Biotech’s Uni-Gold™ RecombigenW HIV test. If
the test result was positive a repeat serological test
was performed utilizing Abbott Determine HIV-1/2.
This was done to avoid false positive results.
Ethics
Permission to carry out the study was obtained from
the National Institute of Medical Research (NIMR) in
Tanzania and the Danish National Committee on Bio-
medical Research Ethics. Informed consent to participate
in the study was obtained from each participant. Women
who were found to have pre-cancerous lesion were trea-
ted by cryotherapy or LEEP based on disease grade.
Similarly those who were found to have invasive cervical
cancer were treated with radiotherapy as per ORCI
protocol. Women who tested HIV positive were assistedto attend the HIV care and treatment clinic. All services
were provided free of charge.
Statistical analysis
Data were entered in EPIINFO version 6.04 and then
exported to SPSS version 13 for analysis. Odds ratios
(ORs) and 95% confidence intervals (CI) were computed
as a measure of association between socioeconomic and
reproductive characteristics and VIA status. Similarly
the association between previous screening attendance
and socioeconomic characteristics, sexual behavior, HIV
status and HR-HPV infection were assessed by ORs.
Multiple logistic regression analysis was used to adjust
the risk estimates. All variables (age, education, parity,
HIV status, HR-HPV, age of sexual intercourse and
number of sexual partners) that were statistically signifi-
cant at a p value of 0.2 or less in the bivariate analysis
were considered for multivariate analysis. Final variable
selection was done using a backward stepwise elimin-
ation process. A P value of ≤ 0.05 was considered signifi-
cant. Multivariate logistic regression was also used to
assess for interaction and confounding. We used the
chunk test to see if there was interaction by comparing
the -2LL (negative two log likelihood) of the reduced
model (no interaction terms) and the full model (with
interaction terms). We found no significant difference
between these two models and concluded that there was
no interaction. All variables were tested for confounding
since they were not effect modifiers. We noted the ORs
for HIV and HR-HPV when each of the variables was left
out of the model and also when it was put back in the
model. The variables that changed the OR of HIV-1 and
HR-HPV by more than 10% were considered confoun-
ders. The variables were tested singly and also as groups
of confounders. All statistical tests were two-sided. We
also performed stratified analysis of HR-HPV and HIV
infection among screened and unscreened women.
Results
Table 1 shows the socioeconomic characteristics of
13,217 women attending cervical cancer screening in
2002–2008 and a subpopulation of 890 women who par-
ticipated in the screening program between February
and June 2008. The subpopulation seemed to be older
and of lower parity.
Table 2 shows the determinants of VIA status among
women in Dar es Salaam. Seven pct. (932/14,107) of the
women screened were found to be VIA positive. In the
bivariate analysis, women aged 45–59 had an increased
crude OR of 1.78 (95% CI: 1.51-2.41) for being VIA posi-
tive in comparison with women in the younger age
group (25–34 years). In the age adjusted analysis,
women who had never attended school or only attended
primary school had statistical significantly increased ORs
Kahesa et al. BMC Public Health 2012, 12:1055 Page 4 of 8
http://www.biomedcentral.com/1471-2458/12/1055of 4.30 and 1.58, respectively, for being VIA positive
compared with women who had attended higher level
education. The women’s marital situation was also asso-
ciated with being VIA positive, more specifically
widowed/separated women had an increased OR of 1.41
(95% CI: 1.17-1.66) for being VIA positive in comparison
with married women. Moreover, women who were mar-
ried at a young age (14–18 years) had an increased OR
of 2.17 (95% CI: 1.37-3.07) for being VIA positive in
comparison with women who were married at age 29
or above. Finally, women who had 1–2 children, 3–4
children and 5 or more children had increased ORs of
2.38, 2.43 and 3.19, respectively, for being VIA positive
in comparison with women who had no children.
Table 3 summarizes the association between screen-
ing attendance and socioeconomic characteristics, sexual
behavior, HIV status and HR-HPV infection. In the
multivariate analysis no significant association was found
between parity, age at first sexual intercourse, number of
sexual partners and screening attendance. In contrast, a
significant association was found between age, education
and HIV status and screening attendances. More specif-
ically, women aged 35–44 and women aged 45 and
above had increased ORs of 1.53 (95% CI: 1.19-2.01) and
2.14 (95% CI: 2.90-1.56) respectively, for participating inTable 1 Comparison of socioeconomic characteristics of wom
and a subpopulation of women who participated in screening
Variable Participated in the screening
program N=13,217
Age
25-34 4552(34.4)
35-44 5028(38.0)
45-59 3637(27.5)
Parity
0 536(4.0)
1-2 3671(27.8)
3-4 4041(30.6)
≥ 5 4457(33.7)
Missing 512(3.9)
Educational Level
No formal education 1172( 8.9)
Primary school 7118( 53.9 )
Sec school and above 4915( 37.2 )
Missing 12(0.1)
Marital Status
Married 10801(81.7)
Single 542(4.1)
Widowed/Separated 1849(14.0)
Missing 25(0.2)the screening program in comparison with women who
were aged 25–34. In addition, women with no formal
education had increased OR of 1.96 (95% CI:1.23-3.17)
for participating in the screening program in comparison
with women who had attended secondary school. Finally,
HIV positive women had an increased OR of 1.59 (95%
CI: 1.14-2.25) for participating in the screening program
in comparison with HIV negative women. No significant
association was observed between HR-HPV infection
and screening attendances.
Stratified analysis of HR-HPV and HIV infection
among screened and unscreened women is summarized
in Table 4. Women who attended screening were more
likely to have HR-HPV infection as well as HIV infection
in comparison with unscreened women.
Discussion
In this study high age, low education, being widowed/
separated, being married at a young age and being of
high parity were associated with VIA positivity. Screen-
ing attendance was associated with being aged above 35,
having no formal education and being HIV positive.
To our knowledge this is the first epidemiological
study which has attempted to elicit risk factors for VIA
positivity and screening attendance in Tanzania. Severalen attending cervical cancer screening (2002-Jan 2008)
between February and June 2008
Subpopulation of women
who had participated in the
screening program N=890
p-value
259(29.1)
340(38.2) 0.01
291(32.7)
79(8.9)
307(34.5)
293(33.0) < 0.001
210(23.6)
74(8.3)
529(59.4) 0.05
287(32.2)
732(82.2) 0.16
37(4.2)
115(12.9)
6(0.7)
Table 2 Determinants of VIA positivity among women in Dar es Salaam, Tanzania
Variable VIA positive
N=932
VIA negative
N=13175
OR (95% CI) Age-adjusted
OR (95% CI)
Age
25-34 256(27.5) 4555(34.6) 1
35-44 319(34.2) 5049(38.3) 1.11(0.94-1.33)
45-59 357(38.3) 3570(27.1) 1.78(1.51-2.41)
Educational Level
No formal education 217(23.3) 1029(7.8) 4.87(4.04-6.03) 4.30(3.50-5.31)
Primary school 499(53.5) 7148(54.2) 1.64(1.45-1.91) 1.58(1.33-1.87)
Sec. school or above 213(22.8) 4989(37.9) 1 1
Missing 3(0.3) 9(0.1)
Marital Status
Married 710(76.2) 10823(82.1) 1 1
Single 22(2.4) 557(4.2) 0.64(0.42-0.93) 1.05(0.66-1.62)
Widowed/Separated 198(21.2) 1766(13.4) 1.71(1.44-2.02) 1.41(1.17-1.66)
Missing 2(0.2) 29 (0.2)
Age at Marriage
14-18 362(38.8) 3228(24.5) 2.32(1.62-3.34) 2.17(1.37-3.07)
19-23 351(37.7) 5271(40.0) 1.38(0.96-1.98) 1.31(0.83-1.92)
24-28 139(14.9) 3075(23.3) 0.94(0.64-1.38) 0.91(0.62-1.37)
≥ 29 37(4.0) 767(5.8) 1 1
Missing 43(4.6) 834(6.3)
Parity
0 15(1.6) 600(4.6) 1 1
1-2 224(24.0) 3754(28.5) 2.38(1.41-4.05) 2.38 (1.40-4.08)
3-4 248(26.6) 4086(31.0) 2.41(1.43-4.32) 2.43(1.43-4.17)
≥ 5 431(46.2) 4237(32.1) 4.02(2.42-6.85) 3.19(1.84-5.48)
Missing 14(1.5) 498(3.8)
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ings and whether the sample of unscreened women can
be considered a representative sub sample of the target
group of women, who had never attended screening,
may be questioned. However, to avoid selection bias and
to assure as high representativity as possible, cluster
randomisation was used to recruit women who had
never participated in the screening program. When fo-
cusing on the screened women, the subsample appeared
to be older than the full screened population. This may
have biased the findings and resulted in an overesti-
mation of the association between high age and screen-
ing attendance.
The VIA positivity rate among the 14,107 women
screened at ORCI during the period 2002–2008 was 7%.
In other cross-sectional studies, the proportion of VIA
positive women varies from 2% to 16% [7,14,15]. It has
been suggested that this observed heterogeneity in VIA
positivity rates may be due to factors other than diseaseprevalence [16]. Hence, when discussing the validity of
VIA as a screening method for cervical cancer there
is concern about a lack of standardized test definition,
differences in test providers skills, underlying prevalence
of other sexually transmitted infections and lack of uni-
formity in the application of gold standard for disease
definition [17]. These considerations should be taken
into account in the interpretation of the VIA positivity
rate reported in the present study.
VIA positivity was significantly correlated with being
widowed/separated, being of high parity, being married
at a young age and being of low education. Women who
are separated or widowed may have higher number of
lifetime sexual partners in comparison with married
women and as number of lifetime sexual partners
increases the risk of HPV infection they are more sus-
ceptible for developing precancerous lesions [18]. High
parity is another well-known risk factor for precancerous
lesions [19], this association is most likely due to
Table 3 Socioeconomic characteristics, sexual behavior, HIV status and HR-HPV infection among screened and
unscreened women
Variable Participated in the screening
program N=890
Did not participate in the
screening program N=845
OR (95% CI) Adjusted*
OR (95% CI)
Age
25-34 259(29.1) 332(39.3) 1 1
35-44 340(38.2) 304(36.0) 1.43(1.14-1.18) 1.53(1.19-2.01)
45-59 291(32.7) 209(24.7) 1.78(1.39-2.29) 2.14(1.56-2.90)
Parity
0 79(8.9) 113(13.4) 1 1
1-2 307(34.5) 319(37.8) 1.38(0.99-1.91) 1.34(0.94-1.90)
3-4 293(33.0) 265(31.4) 1.58(1.43-4.32) 1.19(0.82-1.74)
≥ 5 210(23.6) 148(17.5) 2.02(1.42-2.89) 1.28(0.84-1.96)
Educational Level
No formal education 74(8.3) 49(5.8) 1.50(0.97-2.23) 1.96(1.23-3.17)
Primary school 529(59.4) 516(61.1) 1.01(0.81-1.23) 1.06(0.50-1.51)
Sec school and above 287(32.2) 280(33.1) 1 1
Age at 1st sexual intercourse
≤15 87(9.8) 89(10.5) 0.81(0.56-1.61) 0.75(0.49-1.15)
16-20 614(68.9) 600(71.0) 0.96(0.69-1.31) 0.83(0.63-1.09)
≥21 189(21.2) 156(18.5) 1 1
No. of Sexual partners
≤1 334(37.5) 313(37.0) 1 1
2-3 376(42.2) 341(40.4) 1.03(0.83-1.29) 1.07(0.85-1.36)
≥4 180(20.2) 191(22.6) 0.94(0.68-1.15) 0.88(0.66-1.17)
HIV status
Positive 107(12.0) 74(8.8) 1.51(1.08-2.06) 1.59(1.14-2.25)
Negative 694(78.0) 715(84.6) 1
Missing 89(10.0) 56(6.6)
HR-HPV
Positive 128(17.8) 169(18.0) 1.06(0.84-1.36) 0.95(0.72-1.36)
Negative 634(75.8) 688(81.4.) 1
Missing 57(6.4) 5(0.6)
*We adjusted for age, parity, education, age of 1st sexual intercourse, no of sexual partners, HIV status and HR-HPV.
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hormonal adjustment during and after pregnancies
which may create an entry point for the HPV virus. The
found association between marriage at a young age and
VIA positivity is consistent with a Nigerian study where
marriage at early age was reported to be a risk factor for
being VIA positive [20]. In line with this, a pooled ana-
lysis of case–control studies from eight developing coun-
tries have documented that early age at first sexual
intercourse and early pregnancy are risk factors for cer-
vical cancer [21]. The study further documented that the
reported age at first sexual intercourse and age at first
marriage correlated for 92% of the women [21]. These
findings support a hypothesis that early age sexualintercourse is a risk factor for invasive cervical carcin-
oma. This hypothesis is further supported by a study
conducted among married adolescent girls in urban cen-
ters in Kenya and Zambia which found that early mar-
riage increases coital frequency, decreases condom use
and virtually eliminates girls' ability to abstain from sex
[22]. Furthermore, for women in some parts of the
world, the behavior that puts them at risk of HIV infec-
tion and most likely HR-HPV infection is unprotected
sex within marriage [23]. Although married girls are less
likely than single girls to have multiple partners, this
protective behavior may be outweighed by their greater
exposure via unprotected sex with partners who have
higher rates of infection, or if their husband has
Table 4 Stratified analysis of HR-HPV and HIV infection among screened and unscreened women
Participated in the
screening program N (%)
Did not Participate in the
screening program N (%)
OR (95% CI) aOR (95% CI)*
HR-HPV pos
HIV pos 43(30.9) 34(24.3) 1.43(0.82-2.40) 1.90(1.06-5.74)
HIV neg 96(69.1) 106(75.7) 1 1
HR-HPV neg
HIV pos 56(9.1) 40(6.2) 1.51(0.99-2.31) 1.42(0.81 - 3.76)
HIV neg 561(90.9) 606(93.8) 1 1
* adjusted for age.
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association between VIA positivity and poor education
may be explained by the fact that women who have not
attended school are less informed about safe sex and
condom use and are thereby at increased risk of acquir-
ing a sexual transmitted infection, including HR-HPV
infection.
In a low income setting, it may be argued that women
who are widowed/separated, women who are having
many children and women who are poorly educated
share in common that they are at greater risk of being in
a financial constraint situation and this may influence
their health seeking behavior. A situation which together
with the fact that they are at increased risk of HR-HPV
infection place them at double jeopardy for developing
cervical cancer. The association between low socioeco-
nomic position and risk of developing cervical cancer
has also been documented in a meta-analysis based on
57 studies [24]. The pooled analysis of the included
studies found an increased risk of approximately 100%
between high and low social classes for the development
of invasive cervical cancer and an increased risk of ap-
proximately 60% for cervical dysplasia and carcinoma in
situ. The increased risk was apparent in all regions, al-
though it was stronger in America, Asia and Africa than
in Europe.
HIV status was found to be significantly associated
with screening attendance. Hence women who were
HIV positive were more likely to participate in the
screening program than HIV negative women were. This
finding reflects the existence of a referral linkage be-
tween the HIV care and treatment program and the cer-
vical cancer screening program in Dar es Salaam, where
women who are tested HIV positive are encouraged to
be screened for cervical cancer. The fact that HIV-
infected women are more often infected with HR-HPV
compared to HIV-uninfected women documents the
need of such linkage. Based on our findings it may be
argued that in countries with high HIV prevalence, the
integration of cervical cancer into HIV care and treat-
ment provides an ideal platform to reach HIV positive
women who are at increased risk of developing cervicalcancer. The cost effectiveness of this approach has also
been documented in a Zambian study which showed
that such integration allowed early detection of cervical
cancer in HIV-infected women [25].
An association between HR-HPV infection and HIV
infection was found. As the study design was cross sec-
tional, it is not possible to determine whether the
women acquired the HPV or the HIV infection first.
One explanation behind the found association may be
that HIV positive women are less likely to clear an HPV
infection [9,26,27] and are more susceptibility to infec-
tion with multiple types of HPV [28-30]. In addition, it
has also been suggested that HIV may be activating a
dormant HPV infection and thus increase the risk of
HPV-related disease [31].
Conclusion
The findings from the present study indicate that
women who are widowed/separated, of high parity, of
low education and married at a young age are more
likely to be VIA positive and thus at risk of developing
cervical cancer. The study further documents that a
referral linkage between the HIV care and treatment
program and the cervical cancer screening program is in
place in the setting studied where HIV positive women
were more likely to participate in the screening program
than HIV negative women were. To increasingly reach
socially deprived women, cervical cancer screening
awareness campaigns should be performed and integrat-
ing cervical cancer screening in existing reproductive
health care programs should be considered.
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